Literature DB >> 2150878

Neuropeptide converting enzyme activities in CSF of low back pain patients.

Markku T Hyyppä1, Hannu Alaranta, Kari Lahtela, Finn Nykvist, Matti Hurme, Fred Nyberg, Pierre Le Grevés, Tsukasa Sakurada, Lars Terenius.   

Abstract

The activity levels of a dynorphin converting enzyme (DCE), a substance P endopeptidase (SPE) and a substance P alpha-amidating enzyme (SP-GLYE) were measured in the cerebrospinal fluid (CSF) of 90 patients with chronic low back pain, sciatica and neurological signs of rhizopathy. The DCE activity was significantly higher in men than in women. Age was related to the DCE activity independent of sex, i.e., older patients had higher enzyme activity. The activities of two substance P converting enzymes were not related to sex or age. Self-reported pain experience and affective covariates (anxiety, depression, hostility, somatization) of pain, and myelography data were not found to be related to the enzyme activity levels once adjustment had been made for sex and age. The activity levels of the enzymes measured here had no predictive value for the long-term outcome of rehabilitation and therapy at the 5-year follow-up of the patients. The sex difference in DCE activity provides further evidence in favor of the role of gender in the psychoendocrine coping with pain distress.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2150878     DOI: 10.1016/0304-3959(90)91069-U

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  3 in total

1.  Substance P immunoreactive fibers of synovial tissue in patients with anterior cruciate ligament injury.

Authors:  Bo Zhang; Takeshi Muneta; Kazuyoshi Yagishita; Ichiro Sekiya
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2006-01-04       Impact factor: 4.342

2.  Nociceptive aspects of fibromyalgia.

Authors:  A A Larson; K J Kovács
Journal:  Curr Pain Headache Rep       Date:  2001-08

3.  Novel insights into peptide amidation and amidating activity in the human circulation.

Authors:  Paul Kaufmann; Andreas Bergmann; Olle Melander
Journal:  Sci Rep       Date:  2021-08-04       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.